Abstract
Purpose
To evaluate how effective methylene blue injection was at treating intractable idiopathic pruritus ani.
Methods
A comprehensive literature search of the PubMed, Embase, Cochrane library, and Web of Science databases was conducted. All clinical studies (prospective and retrospective) that evaluated the efficacy of methylene blue in treating intractable idiopathic pruritus ani were included. Studies that reported the resolution rate, after a single injection and after a second injection, the recurrence rate, symptom scores, and transient complications of methylene blue injections in treating intractable idiopathic pruritus ani were included.
Results
The seven selected studies included 225 patients with idiopathic pruritus ani. The resolution rates after a single injection and after a second injection was 0.761 (0.649–0.873, P < 0.01, I2 = 69.06%) and 0.854 (0.752–0.955, P < 0.01, I2 = 77.391%), respectively, the remission rates at 1, 3, and 5 years were 0.753 (0.612–0.893, P < 0.001), 0.773 (0.675–0.871, P < 0.001) and 0.240 (0.033–0.447, P < 0.001), respectively, the effect value of the merger was 0.569 (0.367–0.772, P < 0.001, I2 = 79.199%), and the recurrence rates at 1, 2, 3, and < 1 year were 0.202 (0.083–0.322, P < 0.001), 0.533 (0.285–0.781, P < 0.001), 0.437 (−0.044, 0.917, P < 0.001) and 0.067 (0.023–0.111, P < 0.001), respectively. The effect value of the merger was 0.223 (0.126–0.319, P < 0.001, I2 = 75.840).
Conclusion
Using methylene blue injections to treat intractable idiopathic pruritus ani is relatively efficacious, resulting in a relatively low recurrence rate and no severe complications. However, the available literature was of poor quality. Therefore, higher quality studies are necessary to confirm that methylene blue injection is efficacious for pruritus ani, such as a randomized prospective multicenter studies.
Similar content being viewed by others
References
Abramowitz L, Benabderrahmane M, Pospait D, Philip J, Laouénan C (2014) The prevalence of proctological symptoms amongst patients who see general practitioners in France. Eur J Gen Pract 20(4):301–306
Hsieh JC, Hägermark O, Ståhle-Bäckdahl M, Ericson K, Eriksson L, Stone-Elander S, Ingvar M (1994) Urge to scratch represented in the human cerebral cortex during itch. J Neurophysiol 72(6):3004–3008
Nasseri YY, Osborne MC (2013) Pruritus ani: diagnosis and treatment. Gastroenterol Clin North Am 42(4):801–813
Oueidat D, Bou Assi T, Jurjus A (2014) Pruritus ani: more than a decade of personal experience in Lebanon. J med liban Leb med J 62(4):203–206
Etter L, Myers SA (2002) Pruritus in systemic disease: mechanisms and management. Dermatol Clin 20(3):459–472
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71
Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J (2003) Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 73(9):712–716
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560
Wolloch Y, Dintsman M (1979) A simple and effective method of treatment for intractable pruritus ani. Am J Proctol Gastroenterol Colon Rectal Surg 30(1):34–36
Farouk R, Lee PW (1997) Intradermal methylene blue injection for the treatment of intractable idiopathic pruritus ani. Br J Surg 84(5):670
Botterill ID, Sagar PM (2002) Intra-dermal methylene blue, hydrocortisone and lignocaine for chronic, intractable pruritus ani. Col Dis 4(2):144–146
Mentes BB, Akin M, Leventoglu S, Gultekin FA, Oguz M (2004) Intradermal methylene blue injection for the treatment of intractable idiopathic pruritus ani: results of 30 cases. Tech Coloproctol 8(1):11–14
Sutherland AD, Faragher IG, Frizelle FA (2009) Intradermal injection of methylene blue for the treatment of refractory pruritus ani. Col Dis 11(3):282–287
Samalavicius NE, Poskus T, Gupta RK, Lunevicius R (2012) Long-term results of single intradermal 1 % methylene blue injection for intractable idiopathic pruritus ani: a prospective study. Tech Coloproctol 16(4):295–299
Kim JH, Kim DH, Lee YP (2019) Long-term follow-up of intradermal injection of methylene blue for intractable, idiopathic pruritus ani. Tech Coloproctol 23(2):143–149
Oz M, Lorke DE, Hasan M, Petroianu GA (2011) Cellular and molecular actions of methylene blue in the nervous system. Med Res Rev 31(1):93–117
Wainwright M, Crossley KB (2002) Methylene blue a therapeutic dye for all seasons? J Chemother 14(5):431–443
An R (1968) Atlas of the Operations on the Rectum and Colon. Moscow Meduch Posovie. 14:431
Eusebio EB, Graham J, Mody N (1990) Treatment of intractable pruritus ani. Dis Colon Rectum 33(9):770–772
Ortega AE, Delgadillo X (2019) Idiopathic pruritus ani and acute perianal dermatitis. Clin Colon Rectal Surg 32(5):327–332
Lysy J, Sistiery-Ittah M, Israelit Y, Shmueli A, Strauss-Liviatan N, Mindrul V, Keret D, Goldin E (2003) Topical capsaicin–a novel and effective treatment for idiopathic intractable pruritus ani: a randomised, placebo controlled, crossover study. Gut 52(9):1323–1326
Suys E (2012) Randomized study of topical tacrolimus ointment as possible treatment for resistant idiopathic pruritus ani. J Am Acad Dermatol 66(2):327–328
Ucak H, Demir B, Cicek D, Dertlioglu SB, Akkurt ZM, Ucmak D, Halisdemir N (2013) Efficacy of topical tacrolimus for the treatment of persistent pruritus ani in patients with atopic dermatitis. J Dermatolog Treat 24(6):454–457
Funding
This study was supported by the National Natural Science Foundation of China [grant number 81704082], the Medical Scientific Research Foundation of Zhejiang Province, China [grant number 2020RC086], the Zhejiang Traditional Chinese Medicine Scientific Research Foundation [grant number 2020ZB095], and the Zhejiang Provincial Natural Science Foundation of China [grant number LQ20G030015].
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
For this type of study formal consent is not required.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jia, W., Li, Q., Ni, J. et al. Efficacy and safety of methylene blue injection for intractable idiopathic pruritus ani: a single-arm metaanalysis and systematic review. Tech Coloproctol 27, 813–825 (2023). https://doi.org/10.1007/s10151-023-02825-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10151-023-02825-y